Andrew Spaventa
CIK 1859701 · Chief Executive Officer · last filed 2025-02-25
Andrew Spaventa is a Chief Executive Officer who has filed 19 SEC Form 4 insider transactions across 1 company since 2021. Across all open-market trades the lifetime net is +$12.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
19
$12.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Singular Genomics Systems, Inc. (OMIC) Delisted | Chief Executive Officer | 144,332 | $20.01 | $2.89M | $12.2K | 18 | 2025-02-14 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-25 | — | Disp (D) | −143,310 | $0 | |
| 2025-02-14 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +1,107 | -$15.9K | EDGAR |
| 2024-12-17 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +306 | -$3.6K | EDGAR |
| 2024-11-13 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +1,212 | -$15.7K | EDGAR |
| 2024-09-17 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +312 | -$2.2K | EDGAR |
| 2024-08-14 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +1,225 | -$4.8K | EDGAR |
| 2024-06-18 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +14,584 | $0 | EDGAR |
| 2024-05-13 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +57,188 | $0 | EDGAR |
| 2024-03-19 | Singular Genomics Systems, Inc. (OMIC) Delisted | Mixed | +14,583 | $0 | EDGAR |
| 2024-02-13 | Singular Genomics Systems, Inc. (OMIC) Delisted | Grant (A) | — | $0 | EDGAR |